Stockreport

This Clinical-Stage Biotech's Tackling a Huge Health Issue, but It Has to Overcome Pessimistic Investors First [The Motley Fool]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF If this company has its way, then heart disease may soon have a new enemy. Over 600,000 Americans die every year because of heart disease, and those deaths are of [Read more]